These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9530344

  • 1. Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts.
    Yamaguchi H, Inokuchi K, Shinohara T, Dan K.
    Cancer Genet Cytogenet; 1998 Apr 01; 102(1):74-7. PubMed ID: 9530344
    [Abstract] [Full Text] [Related]

  • 2. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X, Qing A, Ji P, French SW, Mason H.
    Exp Mol Pathol; 2018 Apr 01; 104(2):130-133. PubMed ID: 29501750
    [Abstract] [Full Text] [Related]

  • 3. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
    Lemes A, Gómez Casares MT, de la Iglesia S, Matutes E, Molero MT.
    Cancer Genet Cytogenet; 1999 Aug 01; 113(1):100-2. PubMed ID: 10459357
    [Abstract] [Full Text] [Related]

  • 4. Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts.
    Cruz SSD, Seabra AD, Macambira LHR, Carneiro DM, Nunes PF, Pontes TB, Mello-Junior FAR, Leão LBC, Cordeiro FNCDS, Carneiro TX, Moreira-Nunes CA, Burbano RMR.
    Genes (Basel); 2022 Mar 25; 13(4):. PubMed ID: 35456386
    [Abstract] [Full Text] [Related]

  • 5. Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.
    Miyashita N, Onozawa M, Suto K, Fujisawa S, Okazaki N, Hidaka D, Ohigashi H, Yasumoto A, Sugita J, Hashimoto D, Matsuno Y, Teshima T.
    Intern Med; 2022 Apr 01; 61(7):1049-1054. PubMed ID: 34511573
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
    Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K.
    Leukemia; 2000 Jan 01; 14(1):169-82. PubMed ID: 10637493
    [Abstract] [Full Text] [Related]

  • 8. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul 01; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 11. Blast crisis of Philadelphia chromosome-positive chronic myeloid leukaemia carrying micro-bcr breakpoint (e19a2 and e191a).
    Ohsaka A, Hoshino S, Kobayashi M, Kudo H, Kawaguchi R.
    Br J Haematol; 2002 Jul 01; 118(1):251-4. PubMed ID: 12100156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H, Tsuchiya S, Morita S, Itano M, Yambe T, Ohasi Y, Minegishi N, Minegishi M, Satou T, Konno T.
    Leukemia; 1994 Sep 01; 8(9):1592-5. PubMed ID: 8090037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P, Santhanam R, Oaks JJ, Eiring AM, Notari M, Blaser BW, Liu S, Trotta R, Muthusamy N, Gambacorti-Passerini C, Druker BJ, Cortes J, Marcucci G, Chen CS, Verrills NM, Roy DC, Caligiuri MA, Bloomfield CD, Byrd JC, Perrotti D.
    J Clin Invest; 2007 Sep 01; 117(9):2408-21. PubMed ID: 17717597
    [Abstract] [Full Text] [Related]

  • 19. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
    Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R.
    Leukemia; 1991 Mar 01; 5(3):191-5. PubMed ID: 2013978
    [Abstract] [Full Text] [Related]

  • 20. Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.
    Huntly BJ, Bench AJ, Delabesse E, Reid AG, Li J, Scott MA, Campbell L, Byrne J, Pinto E, Brizard A, Niedermeiser D, Nacheva EP, Guilhot F, Deininger M, Green AR.
    Blood; 2002 Jun 15; 99(12):4547-53. PubMed ID: 12036887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.